868 related articles for article (PubMed ID: 30143045)
1. Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data.
Young JB; Gauthier-Loiselle M; Bailey RA; Manceur AM; Lefebvre P; Greenberg M; Lafeuille MH; Duh MS; Bookhart B; Wysham CH
Cardiovasc Diabetol; 2018 Aug; 17(1):118. PubMed ID: 30143045
[TBL] [Abstract][Full Text] [Related]
2. Development of risk models for major adverse chronic renal outcomes among patients with type 2 diabetes mellitus using insurance claims: a retrospective observational study.
Wysham CH; Gauthier-Loiselle M; Bailey RA; Manceur AM; Lefebvre P; Greenberg M; Duh MS; Young JB
Curr Med Res Opin; 2020 Feb; 36(2):219-227. PubMed ID: 31625766
[No Abstract] [Full Text] [Related]
3. LEADER Trial Eligibility and Preventable Cardiovascular Events in US Adults with Diabetes: the National Health and Nutrition Examination Surveys 2007-2016.
Fan W; Tong C; Wong ND
Cardiovasc Drugs Ther; 2020 Dec; 34(6):737-743. PubMed ID: 32621045
[TBL] [Abstract][Full Text] [Related]
4. Patients with stable coronary artery disease and type 2 diabetes but without prior myocardial infarction or stroke and THEMIS-like patients: real-world prevalence and risk of major outcomes from the SNDS French nationwide claims database.
Blin P; Darmon P; Henry P; Guiard E; Bernard MA; Dureau-Pournin C; Maizi H; Thomas-Delecourt F; Lassalle R; Droz-Perroteau C; Moore N
Cardiovasc Diabetol; 2021 Nov; 20(1):229. PubMed ID: 34823531
[TBL] [Abstract][Full Text] [Related]
5. Differences in All-Cause Health Care Utilization and Costs in a Type 2 Diabetes Mellitus Population with and Without a History of Cardiovascular Disease.
Mehta S; Ghosh S; Sander S; Kuti E; Mountford WK
J Manag Care Spec Pharm; 2018 Mar; 24(3):280-290. PubMed ID: 29485954
[TBL] [Abstract][Full Text] [Related]
6. Peripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus.
Brownrigg JR; de Lusignan S; McGovern A; Hughes C; Thompson MM; Ray KK; Hinchliffe RJ
Heart; 2014 Dec; 100(23):1837-43. PubMed ID: 25095826
[TBL] [Abstract][Full Text] [Related]
7. Validation of a New Risk Measure for Chronic Obstructive Pulmonary Disease Exacerbation Using Health Insurance Claims Data.
Stanford RH; Nag A; Mapel DW; Lee TA; Rosiello R; Vekeman F; Gauthier-Loiselle M; Duh MS; Merrigan JF; Schatz M
Ann Am Thorac Soc; 2016 Jul; 13(7):1067-75. PubMed ID: 27070274
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular event costs in patients with Type 2 diabetes mellitus.
Johnston SS; Sheehan JJ; Shah M; Cappell K; Princic N; Smith D; Kalsekar I
J Med Econ; 2015; 18(12):1032-40. PubMed ID: 26189723
[TBL] [Abstract][Full Text] [Related]
9. Administrative claims data to support pragmatic clinical trial outcome ascertainment on cardiovascular health.
Ma Q; Chung H; Shambhu S; Roe M; Cziraky M; Jones WS; Haynes K
Clin Trials; 2019 Aug; 16(4):419-430. PubMed ID: 31081367
[TBL] [Abstract][Full Text] [Related]
10. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
Ou HT; Chang KC; Li CY; Wu JS
Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017.
Einarson TR; Acs A; Ludwig C; Panton UH
Cardiovasc Diabetol; 2018 Jun; 17(1):83. PubMed ID: 29884191
[TBL] [Abstract][Full Text] [Related]
12. Improved trends in cardiovascular complications among subjects with type 2 diabetes in Korea: a nationwide study (2006-2013).
Jung CH; Chung JO; Han K; Ko SH; Ko KS; Park JY;
Cardiovasc Diabetol; 2017 Jan; 16(1):1. PubMed ID: 28057001
[TBL] [Abstract][Full Text] [Related]
13. Incidence of cardiovascular events and vascular interventions in patients with type 2 diabetes.
Engelen SE; van der Graaf Y; Stam-Slob MC; Grobbee DE; Cramer MJ; Kappelle LJ; de Borst GJ; Visseren FLJ; Westerink J;
Int J Cardiol; 2017 Dec; 248():301-307. PubMed ID: 28802735
[TBL] [Abstract][Full Text] [Related]
14. On the importance of global cardiovascular risk assessment in people with type 2 diabetes.
Echouffo-Tcheugui JB; Kengne AP
Prim Care Diabetes; 2013 Jul; 7(2):95-102. PubMed ID: 23623209
[TBL] [Abstract][Full Text] [Related]
15. Development of a cardiovascular diseases risk prediction model and tools for Chinese patients with type 2 diabetes mellitus: A population-based retrospective cohort study.
Wan EYF; Fong DYT; Fung CSC; Yu EYT; Chin WY; Chan AKC; Lam CLK
Diabetes Obes Metab; 2018 Feb; 20(2):309-318. PubMed ID: 28722290
[TBL] [Abstract][Full Text] [Related]
16. The Look AHEAD Trial: Implications for Lifestyle Intervention in Type 2 Diabetes Mellitus.
Dutton GR; Lewis CE
Prog Cardiovasc Dis; 2015; 58(1):69-75. PubMed ID: 25936906
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular risk prediction in a population with the metabolic syndrome: Framingham vs. UKPDS algorithms.
Zomer E; Liew D; Owen A; Magliano DJ; Ademi Z; Reid CM
Eur J Prev Cardiol; 2014 Mar; 21(3):384-90. PubMed ID: 22588087
[TBL] [Abstract][Full Text] [Related]
18. Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mellitus.
Berkelmans GFN; Gudbjörnsdottir S; Visseren FLJ; Wild SH; Franzen S; Chalmers J; Davis BR; Poulter NR; Spijkerman AM; Woodward M; Pressel SL; Gupta AK; van der Schouw YT; Svensson AM; van der Graaf Y; Read SH; Eliasson B; Dorresteijn JAN
Eur Heart J; 2019 Sep; 40(34):2899-2906. PubMed ID: 30629157
[TBL] [Abstract][Full Text] [Related]
19. Long-term cardiovascular risk and costs for myocardial infarction survivors in a US commercially insured population.
Kern DM; Mellström C; Hunt PR; Tunceli O; Wu B; Westergaard M; Hammar N
Curr Med Res Opin; 2016; 32(4):703-11. PubMed ID: 26709864
[TBL] [Abstract][Full Text] [Related]
20. Consultation rates in people with type 2 diabetes with and without vascular complications: a retrospective analysis of 141,328 adults in England.
Abner S; Gillies CL; Shabnam S; Zaccardi F; Seidu S; Davies MJ; Adeyemi T; Khunti K; Webb DR
Cardiovasc Diabetol; 2022 Jan; 21(1):8. PubMed ID: 35012531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
